Sector
PharmaceuticalsOpen
₹1.12Prev. Close
₹1.17Turnover(Lac.)
₹11.54Day's High
₹1.12Day's Low
₹1.1252 Week's High
₹1.3652 Week's Low
₹0.52Book Value
₹1.12Face Value
₹1Mkt Cap (₹ Cr.)
208.2P/E
28EPS
0.04Divi. Yield
019 Dec 2024
12:00 AM
EGM
21 Jul 2023
12:00 AM
Split
13 Dec 2024
12:00 AM
Rights
3 Jun 2025
12:00 AM
Board Meeting
Agenda : Audited Result
19 Sep 2024
12:00 AM
AGM
Announcement Date: 19 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 49.42 | 12.34 | 12.34 | 6.17 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 6.42 | 6.37 | 4.39 | 8.33 |
Net Worth | 55.84 | 18.71 | 16.73 | 14.5 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Revenue | 21.03 | 41.08 | 55.1 | 50.7 |
yoy growth (%) | -48.79 | -25.44 | 8.69 | 173.07 |
Raw materials | -25.04 | -46.27 | -50.36 | -46.21 |
As % of sales | 119.03 | 112.62 | 91.38 | 91.15 |
Employee costs | -0.04 | -0.29 | -0.3 | -0.38 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Profit before tax | 3.08 | 0.11 | 2.44 | 2.27 |
Depreciation | -0.11 | -0.12 | -0.09 | -0.03 |
Tax paid | -0.85 | -0.02 | -0.62 | -0.61 |
Working capital | -0.19 | 5.2 | 4.82 | 11.95 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -48.79 | -25.44 | 8.69 | 173.07 |
Op profit growth | -43.02 | -726.78 | -62.48 | 540.6 |
EBIT growth | 201.86 | -69.27 | 2.87 | 494.39 |
Net profit growth | 2,420.56 | -95.13 | 9.26 | 1,435.81 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Chinmay pradhan
Director
Krunalbhai Desai
Director
NITINKUMAR ASHOKKUMAR TOMAR
G1 Ground Floor VR Complex,
Nr Sanathal Cross Rd SP RingRd,
Gujarat - 382210
Tel: 91-79-48402525
Website: https://muraeglobal.com
Email: -
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Murae Organisor Limited was originally incorporated as Earum Pharmaceuticals Private Limited on July 26, 2012 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, Company was co...
Read More
Reports by Murae Organisor Ltd
What is the Murae Organisor Ltd share price today?
What is the Market Cap of Murae Organisor Ltd?
What is the PE and PB ratio of Murae Organisor Ltd?
What is the 52 Week High and Low of Murae Organisor Ltd?
What is the CAGR of Murae Organisor Ltd?
What is the shareholding pattern of Murae Organisor Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.